Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers
- PMID: 7508883
- DOI: 10.1016/0046-8177(94)90169-4
Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers
Abstract
The prostatic epithelium is composed of three distinct cell populations: secretory luminal, basal, and endocrine-paracrine cells. It is currently unknown whether these basic epithelial cell types are related in a hierarchical pathway of differentiation or are independent and separate entities. In the present study we used double-label techniques for cell-specific markers to search for multidirectional differentiation in normal, hyperplastic, and neoplastic prostate tissue. In normal and hyperplastic conditions subsets of basal cells revealed synchronous expression of basal cell-specific cytokeratins and the prostate-specific antigen, indicating intermediate differentiation between basal and secretory luminal cell types. Furthermore, endocrine-paracrine cells of the closed type focally showed simultaneous expression of chromogranin A and basal cell-specific cytokeratins. These findings highlight the phenotypic plasticity of the basal cell layer in the human prostate. In prostatic adenocarcinoma co-expression of exocrine (prostate-specific antigen) and endocrine (chromogranin A) markers was detected frequently in subsets of malignant cells. Conversely, this amphicrine phenotype was rarely found in hyperplastic glands. The occurrence of multidirectional differentiation within the prostatic endocrine cell system may indicate that endocrine-paracine cells derive from pluripotent stem cells of endodermal origin. Furthermore, the phenotypic plasticity of basal cells suggests that this epithelial compartment houses stem cell populations that give rise to all epithelial cell lineages encountered in the normal, hyperplastic, and neoplastic human prostate.
Similar articles
-
Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.Int Urol Nephrol. 1998;30(6):731-44. doi: 10.1007/BF02564862. Int Urol Nephrol. 1998. PMID: 10195869
-
Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.Prostate. 1996 Feb;28(2):98-106. doi: 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J. Prostate. 1996. PMID: 8604398 Review.
-
Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.Hum Pathol. 1995 Feb;26(2):167-70. doi: 10.1016/0046-8177(95)90033-0. Hum Pathol. 1995. PMID: 7532147
-
Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate.Prostate. 1991;19(2):91-8. doi: 10.1002/pros.2990190202. Prostate. 1991. PMID: 1717965
-
[New aspects in histogenesis of hyperplasia and cancers of the prostate].Verh Dtsch Ges Pathol. 1993;77:31-9. Verh Dtsch Ges Pathol. 1993. PMID: 7511302 Review. German.
Cited by
-
Unraveling molecular characteristics and tumor microenvironment dynamics of neuroendocrine prostate cancer.J Cancer Res Clin Oncol. 2024 Oct 16;150(10):462. doi: 10.1007/s00432-024-05983-0. J Cancer Res Clin Oncol. 2024. PMID: 39412660 Free PMC article. Review.
-
[Implications of estrogens and their receptors for the development and progression of prostate cancer].Pathologe. 2005 Nov;26(6):461-8. doi: 10.1007/s00292-005-0790-1. Pathologe. 2005. PMID: 16220300 German.
-
[New insights into the role of estogens and their receptors in prostate cancer].Urologe A. 2003 Dec;42(12):1594-601. doi: 10.1007/s00120-003-0438-9. Urologe A. 2003. PMID: 14668987 Review. German.
-
Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile.Am J Pathol. 2004 Nov;165(5):1543-56. doi: 10.1016/S0002-9440(10)63412-8. Am J Pathol. 2004. PMID: 15509525 Free PMC article.
-
Prostate cancer: a comprehensive review.Med Oncol. 2000 May;17(2):85-105. doi: 10.1007/BF02796203. Med Oncol. 2000. PMID: 10871814 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials